February 10 ,2010 - Elder Pharmaceuticals Ltd., one of the fastest growing pharmaceutical companies in India. On 10th February 2010 Elder Pharmaceuticals Ltd announced the inauguration of a new manufacturing facility at Langa Road, Dehradun. Located in an excise benefit zone, the Company expects major cost advantages f

Read More >>

August 14 ,2009 - Elder Pharmaceuticals Ltd has announced that a meeting of the Board of Directors of the Company will be held on August 25, 2009, for approving the audited financial results of the Company for the year ended March 31, 2009 and also recommending dividend for the year ended on that date. The said meeti

Read More >>

June 24 ,2009 - Elder Pharmaceuticals is increasing its focus on the rural market. The Mumbai-based company that largely makes active pharmaceutical ingredients plans to increase its sales by 8-9% mainly from rural areas and has allocated Rs 40 crore to strengthen the sales force for this segment, director Alok Sax

Read More >>

June 19 ,2009 - Elder Pharmaceuticals has signed an agreement with US-based MD Anderson Cancer Center to conduct human experiments for its newly-discovered anti-cancer drug. As per the agreement, the cancer centre will invest into human trials in the US, while Elder Pharmaceuticals would retain exclusive manufactur

Read More >>

June 7 ,2009 - Elder Pharma commenced operations in 1988, and is engaged in manufacture of drug formulations in the therapeutic areas of woman healthcare, wound management and nutraceuticals. It also manufactures APIs and generic drugs in small quantities. Elder Pharma is a mid-sized player which follows the non-i

Read More >>

May 8 ,2009 - The net sales for the quarter posted muted growth of 1% to Rs 157.59 crore and net profit declined by 51% to Rs 10.07 crore. The break up of the revenues as per segment as follows: - Women’s Healthcare- Rs 38.98 crore (up by 2%), Pain Management- Rs 18.60 crore (up by 1%), Neutraceuticals – Rs 9.36

Read More >>

May 7 ,2009 - Elder Pharmaceuticals Ltd has announced that during the Board Meeting held on April 29, 2009, the resignation of Mr. Peter Bibby, who had submitted his resignation on health grounds, was placed before the Board and the same was accepted by the Board. During the same meeting the Board appointed Mrs

Read More >>

April 13 ,2009 - By ELDER Pharmaceuticals Monday, 13 April 2009 Setting its sight on the fast growing infection control segment, the Rs 5.5. bn Elder Pharmaceuticals Limited has inked a strategic alliance in this sector with M/s Chemische Fabrik Dr. Weigert GmbH & Co. KG, German and European leader in Equipment,

Read More >>

April 9 ,2009 - Elder Pharmaceuticals March qtr PAT seen at Rs 18.2cr: ICICIdirect.com ICICIdirect.com has come out with its earning estimates on Pharmaceuticals space for the quarter ended March 2009. According to the research firm, Elder Pharmaceuticals March quarter sales are expected to go up by 3.5% to Rs 1

Read More >>

April 5 ,2009 - Elder Pharma ties up with Chemische Fabrik Dr Weigert MUMBAI: City-based Elder Pharmaceuticals has strengthened its presence in the Rs 750 crore infection control segment by tying up with Chemische Fabrik Dr Weigert GmbH, a German equipment, services and technology company. Elder has introdu

Read More >>

March 30 ,2009 - INDIAN pharmaceutical companies with a presence in the sterile injectables space are expanding capacities to cater to growing demand in this segment. Bangalore-based Strides Arcolab, Elder Pharmaceuticals are some of the companies that have laid out plans for growth including expansion of existing u

Read More >>

March 29 ,2009 - Elder Pharma has stepped on the brakes with regard to overseas acquisitions and is focusing instead on consolidating its business over the next couple of years, said Mr Alok Saxena, Elder’s Director-International. Recently, the company terminated its open offer to increase its stake in the UK-ba

Read More >>

March 18 ,2009 - “The Pharmaceutical Leadership Summit 2009” scheduled to be held in Bangalore has been now shifted to Mumbai. The topic of the summit is “Destination India – Challenges & Opportunities” and will be held on Friday, 3rd April 2009. The who’s who of pharma industry like Malvinder Singh of Ranbaxy,

Read More >>

March 2 ,2009 - NeutraHealth says Elders offer likely to be in cash UK-based NeutraHealth Plc confirmed on Monday that the unsolicited offer approach from Indias Elder Pharmaceuticals Ltd at an indicative price of 5.5 pence per share was likely to be solely in cash. On Feb. 27, the distributor of vitamins, supple

Read More >>

December 17 ,2008 - The Economic Times: Mid-sized pharma firm Elder Pharmaceuticals has tied up with Australian pharma firm Global Energy Medicines (GEM) to market the latter’s pain management products in India, reports Rajesh Unnikrishnan in Mumbai. Elder will market Global Energy’s non-invasive, electro-therapy-bas

Read More >>

November 30 ,2008 - Elder Pharmaceuticals, a Rs 550 crore pharmaceutical company is growing organically as well inorganically. The company recently acquired 100 percent stake in three Bulgarian pharma companies through its wholly owned Bulgarian subsidiary Elder Biomeda EAD in a share swap deal. Through organic route,

Read More >>

November 18 ,2008 - Elder Pharma bags award for Innovation ( The Free Press Journal: Mumbai dated 18th Nov, 2008) The Rs. 550 Cr Elder Pharmaceuticals Ltd has received the Impressa award – 2008 in the field of Innovation. “Impressa” is the Italian word for “enterprise.” Instituted in 1999, the awards pioneered the re

Read More >>

October 23 ,2008 - Elder Pharmaceuticals is buying out three small Bulgarian pharma companies through its wholly-owned subsidiary Elder-Biomeda in a share swap deal. The three companies have collective sales of around e8-10 million. All the three companies are sister concerns of Biomeda. In August, Elder enter

Read More >>

October 3 ,2008 - MUMBAI: Elder Pharmaceuticals (EPL) has scaled up its stake in its Nepalese JV by 9% to 49% for around Rs 60 crore. The Rs 550-crore pharma company has set up a 40:60 JV with Universal group of Kathmandu in 2006. “We plan to hike to our stake in the JV to 51% and make it our subsidiary. We have also

Read More >>

September 22 ,2008 - Elder Pharmaceuticals Ltd has been selected for the Lalit Doshi Memorial Award as the best SICOM assisted unit for the year 2007-08. The award is jointly given by Lalit Doshi Memorial Foundation and SICOM Limited, every year. This award was instituted thirteen years ago, in the memory of Late Shri L

Read More >>

July 31 ,2008 - The Mumbai-based Rs 500-crore Elder Pharmaceuticals today announced its unaudited financial results for the first quarter ended 30 June 2008. Review of quarterly financial performance: Elder Pharmaceuticals has reported a robust quarter-on-quarter revenue expansion with total income increase of 2

Read More >>

July 31 ,2008 - MUMBAI, July 31 (Reuters) - Elder Pharmaceuticals Ltd (ELDP.BO: Quote, Profile, Research) expects a minimum 20 percent rise in 2008/09 net profit, aided by new product launches, an official said Thursday after the firm posted a 16 percent rise in first-quarter profit. For the year to March 2009, Mu

Read More >>

July 22 ,2008 - MUMBAI: The California-based bio-pharmaceutical company, Cymbiotics, has signed an in-licensing deal with Elder Pharmaceuticals to market six of its patented products in India. As per the agreement, Elder will market Cymbiotics products in pain management, diabetics, dermatology, besides OTC prod

Read More >>

February 21 ,2008 - The Mumbai based Elder Pharmaceuticals has launched a new product, Phytomega, a unique combination of Omega-3 fatty acids and Phytosterols in the domestic market. It will help to reduce heart disease risks. Phytomega has been licensed to Elder by an Israeli company Enzymotec, which specializes in de

Read More >>

February 14 ,2008 - Elder Pharmaceuticals, a Mumbai-based Rs 500 crore company has announced the launch of its new product – PHYTOMEGA a unique combination of Omega-3 fatty acids & Phytosterols which has been proven to reduce lipid levels in the body. This product has been licensed to Elder by an Israeli company – M/s

Read More >>

July 26 ,2007 - Elder Pharma to acquire 20-per cent stake in UKs Neutra Health news 26 July 2007 Mumbai: Elder Pharmaceuticals Ltd will acquire a 20 per cent strategic stake in Neutra Health PLC, an AIM-listed company in the UK. The deal involves an investment of £5.63 million pounds (Rs46-47 crore). E

Read More >>

July 26 ,2007 - Elder Pharma has bought 20-per cent stake in UK-based Neutra Health, a marketing and distribution company listed on Londons Alternative Investment Market (AIM), for Rs47 crore. (See: Elder Pharma to acquire 20-per cent stake in UKs Neutra Health) Alok Saxena, director, international, Elder Phar

Read More >>

March 14 ,2007 - Elder Pharmaceuticals has entered into an alliance with Laboratorios Farmaceuticos Rovi (ROVI) of Spain to market advanced heparins (anti-thrombotics) in India for treatment and prevention of thrombo-embolic venous diseases like deep vein thrombosis and pulmonary embolism. According to an officia

Read More >>

April 5 ,2006 - The BIRD flu virus may have created a scare and badly hit the poultry industry, but it has thrown up new opportunities for pharmaceutical companies. Elder Pharmaceuticals is launching a spray product, Trigene, to contain bird flu in poultry farms. Trigene, which is already selling in China, is manuf

Read More >>

March 5 ,2005 - Elder Pharma posts excellent results for year ended Mar 05

Read More >>